Yabing Chen Selected Research

cyanoginosin LR (microcystin LR)

4/2022	Male reproductive toxicity induced by Microcystin-leucine-arginine (MC-LR).
11/2021	Chronic MC-LR exposure promoted Aβ and p-tau accumulation via regulating Akt/GSK-3β signal pathway.
11/2019	Blood-brain barrier disruption and inflammation reaction in mice after chronic exposure to Microcystin-LR.
1/2019	Learning and memory deficits and alzheimer's disease-like changes in mice after chronic exposure to microcystin-LR.
11/2018	Chronic exposure to microcystin-leucine-arginine promoted proliferation of prostate epithelial cells resulting in benign prostatic hyperplasia.
10/2017	Microcystin-leucine arginine exhibits immunomodulatory roles in testicular cells resulting in orchitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yabing Chen Research Topics

Disease

12	Neoplasms (Cancer) 06/2022 - 11/2006
10	Vascular Calcification 01/2024 - 05/2008
10	Cholangiocarcinoma 07/2013 - 11/2006
7	Inflammation (Inflammations) 01/2021 - 05/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 07/2011
6	Carcinogenesis 01/2019 - 02/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2016
4	Diabetes Mellitus 02/2021 - 03/2014
3	Atherosclerosis 01/2023 - 05/2008
3	Hypertension (High Blood Pressure) 01/2023 - 01/2011
3	Hyperglycemia 01/2020 - 03/2014
2	Vascular Diseases (Vascular Disease) 01/2022 - 10/2017
2	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 01/2019
2	Memory Disorders (Memory Loss) 11/2021 - 01/2019
2	Obesity 01/2021 - 11/2009
2	Fibrosis (Cirrhosis) 01/2019 - 01/2019
2	Endometriosis 01/2019 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2024
1	Kidney Diseases (Kidney Disease) 01/2024
1	Ulcerative Colitis 12/2023
1	Crohn Disease (Crohn's Disease) 12/2023
1	Lymphopenia (Lymphocytopenia) 11/2023
1	Asthenozoospermia 10/2023
1	Vascular System Injuries 04/2023
1	Ileitis 01/2023
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Arteriosclerosis 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Wilms Tumor (Wilm's Tumor) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2020
1	Abdominal Aortic Aneurysm 01/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2006
9	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2017 - 02/2008
6	Transcription Factors (Transcription Factor)IBA 01/2023 - 05/2008
6	cyanoginosin LR (microcystin LR)IBA 04/2022 - 10/2017
4	CalciumIBA 01/2023 - 12/2008
4	Death Domain ReceptorsIBA 01/2020 - 07/2011
3	Phosphates (Orthophosphate)IBA 01/2024 - 08/2015
3	Apolipoproteins E (ApoE)IBA 01/2020 - 01/2015
3	AcetylglucosamineIBA 01/2020 - 03/2014
3	tigatuzumabIBA 01/2019 - 09/2013
3	Tamoxifen FDA LinkGeneric 09/2015 - 02/2009
2	Hormones (Hormone)IBA 01/2024 - 04/2017
2	CytokinesIBA 12/2023 - 01/2023
2	Polystyrenes (Polystyrene)IBA 01/2023 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 01/2023 - 03/2014
2	6-methyladenineIBA 06/2022 - 01/2021
2	N-methyladenosineIBA 06/2022 - 01/2021
2	SaltsIBA 01/2022 - 01/2011
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2018
2	Parathyroid Hormone (Parathormone)IBA 01/2020 - 08/2015
2	Indicators and Reagents (Reagents)IBA 01/2020 - 06/2011
2	CateninsIBA 11/2018 - 03/2018
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2017 - 09/2013
2	Antisense RNA (Anti-Sense RNA)IBA 01/2017 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 01/2016
2	Trifluoperazine (Stelazine)FDA LinkGeneric 09/2015 - 02/2009
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 01/2012 - 06/2008
1	Adenosine Triphosphate (ATP)IBA 02/2024
1	GossypolIBA 10/2023
1	Becaplermin (PDGF-BB)FDA Link 04/2023
1	Bone Morphogenetic Protein ReceptorsIBA 01/2023
1	Eosinophil Cationic ProteinIBA 01/2023
1	Stromal Interaction Molecule 1IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 11/2021
1	AcidsIBA 02/2021
1	Proline (L-Proline)FDA Link 02/2021
1	epsinIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 02/2021
1	Arginine (L-Arginine)FDA Link 02/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	RNA Demethylase AlkB Homolog 5IBA 01/2021
1	ChromatinIBA 01/2021
1	Autophagy-Related Protein-1 HomologIBA 01/2021
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2021
1	MagnesiumIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	bafilomycin A1IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2021
1	CCAAT-Enhancer-Binding Protein-betaIBA 01/2021
1	Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2021
1	Angiotensin IIIBA 01/2020

Therapy/Procedure

12	Therapeutics 07/2020 - 11/2006
2	Transplantation 11/2023 - 11/2018
1	Drug Therapy (Chemotherapy) 01/2024
1	Ligation 04/2023
1	Chronotherapy 01/2023
1	Precision Medicine 01/2023
1	Complementary Therapies (Alternative Medicine) 07/2020